SEC Form 4 · accession 0001232524-18-000103
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen J Wilson
Officer — SVP, Finance & PAO
Period of report
May 11, 2018
Accepted (ET)
May 15, 2018 · 5:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | May 11, 2018 | S | 3,706 | $165.00 | D | 15,811 | D | |
| Ordinary Shares | May 11, 2018 | S | 54 | $165.005 | D | 15,757 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.